Agios Pharmaceuticals AGIO Product revenue, net — Total Revenue

Similar metrics at other companies

CRNXProduct revenue, net — Total Revenue

$10.31M—

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

BIIBProduct revenue, net — Total Revenue

$1.75B+1.5%

TVTXTotal net product sales — Total Revenue

$124.49M+64.1%

BCRXProduct sales, net — Total revenues

$151.4M+5.3%

TARSProduct sales, net — Total revenues

$145.39M+85.6%

Questions, answered.

What is Agios Pharmaceuticals's product revenue, net — total revenue?

Agios Pharmaceuticals (AGIO) reported product revenue, net — total revenue of $20.75M in Q1 2026.

How has Agios Pharmaceuticals's product revenue, net — total revenue changed year-over-year?

Agios Pharmaceuticals's product revenue, net — total revenue increased by 137.7% year-over-year, from $8.73M to $20.75M.

What is the long-term trend for Agios Pharmaceuticals's product revenue, net — total revenue?

Over 4 years (2021 to 2025), Agios Pharmaceuticals's product revenue, net — total revenue has grown at a 10.0% compound annual growth rate (CAGR), from $36.91M to $54.03M.

What does product revenue, net — total revenue mean?

This metric represents the proportion of total corporate revenue derived specifically from the sale of commercialized pharmaceutical products. It serves as a key indicator of a biopharmaceutical company's transition from a research and development-focused entity to a commercial-stage business. Tracking this ratio helps investors evaluate the company's success in scaling its product portfolio relative to other income streams such as collaboration or licensing revenue.